WilliamMarstonLinehanMD

Surgical Oncology

Chief of Urologic Surgery and the Urologic Oncology Branch, Center for Cancer Research, at the National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Join to view full profile

Dr. Linehan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Linehan's full profile

Already have an account?

Office
9000 Rockville Pike
Bldg 10
Bethesda, MD 20892
Phone+1 301-496-6353

Fax+1 301-402-0922

Education & Training

Duke University HospitalResidency, Urology, 1978 - 1982
Duke University HospitalFellowship, Thoracic Surgery, 1976 - 1978
Duke University HospitalResidency, Surgery, 1974 - 1976
University of Oklahoma Health Sciences CenterInternship, Internal Medicine, 1973 - 1974
University of Oklahoma College of MedicineClass of 1973

Certifications & Licensure

MD State Medical License 1985 - 2026
American Board of Urology Urology

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders Start of enrollment: 1990 Dec 05
Recruiting
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease Start of enrollment: 1998 Mar 12
Recruiting
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer Start of enrollment: 2002 May 13
Recruiting
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer Start of enrollment: 2003 Feb 24
Recruiting
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome Start of enrollment: 2003 Dec 01
Completed
Phase II Study of Vandetanib in Individuals With Kidney Cancer Start of enrollment: 2008 Feb 07
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer.
Daniel R Crooks, Geetha Mariah Cawthon, Christina M Fitzsimmons, Minervo Perez, Christopher J Ricketts
Human Molecular Genetics. 2023-11-03
3 citations
Deep learning-based decision forest for hereditary clear cell renal cell carcinoma segmentation on MRI.
Nathan Lay, Pouria Yazdian Anari, Aditi Chaurasia, Fatemeh Dehghani Firouzabadi, Stephanie Harmon
Medical Physics. 2023-08-01
254 citations
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
Eric Jonasch, Frede Donskov, Othon Iliopoulos, W. Kimryn Rathmell, Vivek Narayan
The New England Journal of Medicine. 2021-11-25

Press Mentions

Celebrating Outstanding Young Urologists: The Gold Cystoscope AwardApril 14th, 2024

Grant Support

Molecular Genetics Of Kidney CancerNational Cancer Institute2007
Molecular Genetics Of Kidney CancerDivision Of Clinical Sciences - Nci1997–2006
Molecular Genetics Of Prostate CancerDivision Of Clinical Sciences - Nci1997–2002
Tumor Suppressor Genes In Genitourinary MalignancyDivision Of Clinical Sciences - Nci1996